Identifying resistance mechanisms against five tyrosine kinase inhibitors targeting the ERBB/RAS pathway in 45 cancer cell lines.

by Zsófia Pénzváltó, Bálint Tegze, A Marcell Szász, Zsófia Sztupinszki, István Likó, Attila Szendrői, Reinhold Schäfer, Balázs Győrffy
Published 2013-01-01

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients

by Csilla Olah, Stephan Tschirdewahn, Michèle J. Hoffmann, Ulrich Krafft, Boris Hadaschik, Peter Nyirady, Attila Szendröi, Orsolya Módos, Anita Csizmarik, Ilona Kovalszky, Henning Reis, Tibor Szarvas
Published 2020-10-01

Bosniak category III cysts are more likely to be malignant than we expected in the era of multidetector computed tomography technology

by Pal Bata, Adam Domonkos Tarnoki, David Laszlo Tarnoki, Attila Marcell Szasz, Gergely Poloskei, Bence Fejer, Janos Gyebnar, Peter Nyirady, Viktor Berczi, Kinga Karlinger, Attila Szendroi
Published 2014-01-01